eNUVIO - Microfabricated Devices for Next-generation Cell Culture Information
Summary
eNUVIO - Microfabricated Devices for Next-generation Cell Culture is a private company. The company currently specializes in the Biotechnology area. Its headquarters is located at CA. The annual revenue of eNUVIO - Microfabricated Devices for Next-generation Cell Culture varies between 1 and 10M. To connect with eNUVIO - Microfabricated Devices for Next-generation Cell Culture employee register on SignalHire.
| Website | enuvio.com |
| Social Links |    |
| Phone Number | +1 (514) 254-5583 |
| Industries | |
| Headquarters address | 5524 Rue St-Patrick, Montreal, Quebec, H4E1A8 CA |
| Company Size | 1-10 employees |
| Specialties | neuroscience, microfluidic devices, neuronal co-culture devices, neuronal compartmentalization devices, 3D muscle culture devices, neuromuscular junction devices, axon guidance device, HTS-compatible co-culture devices, 3D cell culture devices, embryoid body formation devices, HTS spheroid formation and processing devices, organoids, cell culture, custom microfabrication, in vitro models, drug discovery, drug screening, ALS, Alzheimer’s disease, life science |
| Founded | 2016 |
| Estimated Annual Revenue | $1 - 10M |
| Operating Status | Independent Company |
Workforce Turnover
Number of staff members switched
Departmental Headcount Distribution
Corporate Tenure Analytics
Workforce Experience Insights
25% have been with the company for 3 to 4 years50% have been with the company for 5 to 7 years25% have been with the company for 8 to 10 years
Similar Companies
FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
